Intravenous application of a primary sevoflurane metabolite improves outcome in murine septic peritonitis: first results.

PloS one

Volumn 8, Issue 8, 2013, Pages

  Herrmann, Inge K ^a   Castellon, Maricela ^b   Schwartz, David E ^b   Hasler, Melanie ^b   Urner, Martin ^b   Hu, Guochang ^b   Minshall, Richard D ^b   Beck Schimmer, Beatrice ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BIOLOGICAL MARKER; HEXAFLUORO 2 PROPANOL; HIGH MOBILITY GROUP B1 PROTEIN; HMGB1 PROTEIN, MOUSE; IMMUNOLOGIC FACTOR; PROPANOL;

ANIMAL; BLOOD; C57BL MOUSE; CECUM; DRUG SCREENING; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; KAPLAN MEIER METHOD; MALE; METABOLISM; MOUSE; PATHOLOGY; PERITONITIS; SEPSIS; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

ADMINISTRATION, INTRAVENOUS; ANIMALS; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CECUM; DRUG EVALUATION, PRECLINICAL; HMGB1 PROTEIN; IMMUNOLOGIC FACTORS; KAPLAN-MEIER ESTIMATE; MALE; MICE; MICE, INBRED C57BL; PERITONITIS; PROPANOLS; SEPSIS; TRANSAMINASES; TREATMENT OUTCOME;

EID: 84897918019     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072057     Document Type: Article

References (0)